PMID- 33227174 OWN - NLM STAT- MEDLINE DCOM- 20210705 LR - 20210705 IS - 2059-2310 (Electronic) IS - 2059-2302 (Print) IS - 2059-2302 (Linking) VI - 97 IP - 2 DP - 2021 Feb TI - Low incidence of IgA isotype of HLA antibodies in alloantigen exposed individuals. PG - 101-111 LID - 10.1111/tan.14146 [doi] AB - Human leukocyte antigen (HLA) antibodies are induced by pregnancy, transfusion, or transplantation. Serum from transplant recipients is regularly screened for IgG HLA antibodies because of their clinical relevance for transplant outcome. While other isotypes of HLA antibodies, such as IgA may also contribute to the alloimmune response, validated detection assays for IgA HLA antibody detection are lacking. Therefore, we modified the commonly used luminex screening assay for IgG HLA antibody detection (IgG-LMX) into an IgA HLA antibody screening assay (IgA-LMX). Optimization and validation was performed with IgG, IgA1, and IgA2 isotype variants of HLA-specific human recombinant monoclonal antibodies (mAbs). Reactivity patterns of IgA1 and IgA2 isotype HLA-specific mAbs in IgA-LMX were identical to those of the IgG isotype. Cross-reactivity with IgG and IgM antibodies and nonspecific binding to the beads were excluded. Further assay validation showed the absence of IgA HLA antibodies in serum from individuals without alloantigen exposure (n = 18). When the IgA-LMX assay was applied to sera from 289 individuals with known alloantigen exposure through pregnancy (n = 91) or kidney transplantation (n = 198), IgA HLA antibodies were detected in 3.5% of individuals; eight patients on the kidney retransplant waitlist and two women immunized through pregnancy. The majority (90%) of IgA HLA antibodies were directed against HLA class II and were always present in conjunction with IgG HLA antibodies. Results of this study show that this validated IgA-LMX method can serve as a screening assay for IgA HLA antibodies and that the incidence of IgA HLA antibodies in alloantigen exposed individuals is low. CI - (c) 2020 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd. FAU - Car, Helena AU - Car H AUID- ORCID: 0000-0003-1636-0644 AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Karahan, Gonca E AU - Karahan GE AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. FAU - Dreyer, Geertje J AU - Dreyer GJ AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Brand-Schaaf, Simone H AU - Brand-Schaaf SH AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. FAU - de Vries, Aiko P J AU - de Vries APJ AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - van Kooten, Cees AU - van Kooten C AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. AD - Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Kramer, Cynthia S M AU - Kramer CSM AUID- ORCID: 0000-0003-1350-2336 AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Roelen, Dave L AU - Roelen DL AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. FAU - Claas, Frans H J AU - Claas FHJ AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. FAU - Heidt, Sebastiaan AU - Heidt S AUID- ORCID: 0000-0002-6700-188X AD - Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands. AD - Leiden Transplant Center, Leiden University Medical Center, Leiden, The Netherlands. LA - eng PT - Journal Article DEP - 20201202 PL - England TA - HLA JT - HLA JID - 101675570 RN - 0 (HLA Antigens) RN - 0 (Immunoglobulin A) RN - 0 (Immunoglobulin G) RN - 0 (Isoantibodies) RN - 0 (Isoantigens) SB - IM MH - Alleles MH - Antibody Specificity MH - Female MH - HLA Antigens MH - Humans MH - Immunoglobulin A MH - Immunoglobulin G MH - Incidence MH - *Isoantibodies MH - *Isoantigens PMC - PMC7898292 OTO - NOTNLM OT - HLA antibody screening OT - IgA antibody OT - luminex OT - pregnancy OT - transplantation COIS- The authors declare no potential conflict of interest. EDAT- 2020/11/24 06:00 MHDA- 2021/07/06 06:00 PMCR- 2021/02/22 CRDT- 2020/11/23 17:11 PHST- 2020/07/22 00:00 [received] PHST- 2020/09/30 00:00 [revised] PHST- 2020/11/09 00:00 [accepted] PHST- 2020/11/24 06:00 [pubmed] PHST- 2021/07/06 06:00 [medline] PHST- 2020/11/23 17:11 [entrez] PHST- 2021/02/22 00:00 [pmc-release] AID - TAN14146 [pii] AID - 10.1111/tan.14146 [doi] PST - ppublish SO - HLA. 2021 Feb;97(2):101-111. doi: 10.1111/tan.14146. Epub 2020 Dec 2.